Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Posted inIOncology

an exclusive interview with Professor Li Jin from Shanghai GoBroad Cancer Hospital

Posted by By Mourabit Halima 2025.03.15Posted inIOncology0 Shares
Home » an exclusive interview with Professor Li Jin from Shanghai GoBroad Cancer Hospital
YouTube player
Post Views: 882

Share via:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • More
Last updated on 2025.03.15
Mourabit Halima
View All Posts

Post navigation

Previous Post
Trastuzumab and Pertuzumab from QILU PHARMACEUTICAL: A Promising and Reliable Therapeutic Option for Patients with HER2-Positive Breast Cancer Trastuzumab and Pertuzumab from QILU PHARMACEUTICAL: A Promising and Reliable Therapeutic Option for Patients with HER2-Positive Breast Cancer
Next Post
SGBCC 2025丨Dr. Javier Cortés: The Dual-Edged Breakthrough in Early HER2-Positive Breast Cancer Treatment – Innovative Targeted Drug Development and Trial Design Reform SGBCC 2025丨Dr. Javier Cortés: The Dual-Edged Breakthrough in Early HER2-Positive Breast Cancer Treatment – Innovative Targeted Drug Development and Trial Design Reform
  • LinkedIn
  • Twitter
  • Mail
Related Media:
Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
Media Medic Publishing Company Limited(HK)
赛美出版有限公司（香港）
Scroll to Top
  • Facebook
  • X (Twitter)
  • LinkedIn
  • More Networks
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied